Brief: Aiforia Expands Its Portfolio Of CE-IVD Marked Clinical Pathology Solutions

Aiforia Technologies Oyj

20/04/2022 07:33

April 20 (Reuters) - Aiforia Technologies Oyj  AIFORIA.HE :
    * AIFORIA EXPANDS ITS PORTFOLIO OF CE-IVD MARKED CLINICAL
PATHOLOGY SOLUTIONS WITH NEW AI MODEL FOR BREAST CANCER
DIAGNOSTICS
    * ANNOUNCES CE-IVD MARKING OF AIFORIA® CLINICAL AI MODEL FOR
BREAST CANCER; ER

Source text for Eikon:  ID:nWkr1VPM91 
Further company coverage:  AIFORIA.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))